pharma news

News

Ex-Novartis CMO John Tsai joins Daiichi Sankyo

Daiichi Sankyo has named John Tsai as its new global head of R&D, replacing Ken Takeshita, who is stepping down after five years in the role.

News

Hims & Hers buys Australian digital health firm for $1.15bn

Hims & Hers, facing a threat to its compounded medicines business, has ramped up its push for international expansion by buying Eucalyptus Health.

News

Scrabble lettering of Two and One on grass

Makary says FDA will "end two-trial dogma" for approvals

The FDA plans to adopt a new policy that will do away with the default requirement to base regulatory filings for new medicines on two pivotal trials.

News

The word Diabetes surrounded by tablets and syringes

NICE backs changes to NHS' diabetes care pathway

New guidance from NICE on type 2 diabetes management will shake up NHS treatment, with wider use of both SGLT2 inhibitors and GLP-1 agonists.

News

NIH Director Bhattacharya will temporarily run CDC

The long months without stable leadership at the CDC in the US look set to continue, as NIH chief Jay Bhattacharya is named acting director.

News

MSD and Mayo Clinic team up on AI drug discovery

MSD has signed an industry-first deal with the Mayo Clinic that will allow it to use the health system's genomic and clinical data for drug discovery.

Ex-Novartis CMO John Tsai joins Daiichi Sankyo

Hims & Hers buys Australian digital health firm for $1.15bn

Makary says FDA will "end two-trial dogma" for approvals

NICE backs changes to NHS' diabetes care pathway

NIH Director Bhattacharya will temporarily run CDC

MSD and Mayo Clinic team up on AI drug discovery

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks